Trial Profile
Efficacy of Safinamide as measured by Parkinson's KinetiGraphTM in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Safinamide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 26 Sep 2016 New trial record